Background: Perioperative bleeding is a potential complication of robot-assisted laparoscopic radical prostatectomy (RALP) that may worsen outcomes. The role of local hemostatic materials in RALP has not been adequately assessed. We evaluated the hemostatic impact of FloSeal (Baxter International Inc., Fremont, Calif., USA) in RALP. Methods: A retrospective analysis was performed of 392 consecutive patients with prostate cancer who underwent RALP at our institution between February 2008 and July 2014. The patients were divided into 2 consecutive homogenous groups based on the use of FloSeal. Group A included 200 patients who underwent RALP between February 2008 and May 2011, with hemostasis performed using only traditional techniques. Group B included the remaining 192 patients, who underwent RALP between June 2011 and July 2014 and received FloSeal 5 ml after traditional hemostatic methods. We compared the blood transfusion rate, the differences between immediate postoperative hemoglobin (Hb) and mean postoperative day 1 (POD1) Hb levels, difference between POD1 and least Hb levels and difference between immediate postoperative Hb and least Hb levels. Results: The intraoperative use of FloSeal significantly decreased the blood transfusions rate, from 8.5 to 2.1% (p = 0.004). FloSeal was also associated with significant improvements in the difference between the immediate postoperative Hb and POD1 Hb levels (p = 0.03), mean POD1 Hb and least Hb (p = 0.01) and mean immediate postoperative Hb and least Hb levels (p = 0.034). Conclusions: In this study, the use of FloSeal improves hemostatic outcomes in patients undergoing RALP compared with traditional hemostatic techniques, without increase of cost.

Keywords:
Blood transfusion, Cost-effectiveness, FloSeal, Perioperative bleeding, Robot-assisted radical prostatectomy
1.
Stokes ME, Ye X, Shah M, et al: Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011;11:135.
2.
Tiroli M, Conti A, Muzzonigro G: [The use of haemostatic agents in urology]. Urologia 2012;79(suppl 19):99-106.
3.
Achneck HE, Sileshi B, Jamiolkowski RM, et al: A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010;251:217-228.
4.
Sileshi B, Achneck HE, Lawson JH: Management of surgical hemostasis: topical agents. Vascular 2008;16(suppl 1):S22-S28.
5.
David G, Lim S, Gunnarsson C, et al: Similar patient outcomes yet different hospital costs between flowable hemostatic agents. J Med Econ 2015;18:735-745.
6.
Nunez-Nateras R, Hurd KJ, Ferrigni EN, et al: Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent. World J Urol 2013;31:523-527.
7.
Hu JC, Wang Q, Pashos CL, et al: Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol 2008;26:2278-2284.
8.
Ficarra V, Novara G, Artibani W, et al: Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009;55:1037-1063.
9.
De Carlo F, Celestino F, Verri C, et al: Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int 2014;93:373-383.
10.
Echave M, Oyagüez I, Casado MA: Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review. BMC Surg 2014;14:111.
11.
Sammon J, Perry A, Beaule L, et al: Robot-assisted radical prostatectomy: learning rate analysis as an objective measure of the acquisition of surgical skill. BJU Int 2010;106:855-860.
12.
Nishino A, Suzuki M, Ohtani H, et al: Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993;10:167-179.
13.
Zeltser I, Dugi D, Gupta A, et al: Does topical haemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle? BJU Int 2008;102:1005-1007.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.